# Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI

> **NCT04864717** · PHASE4 · UNKNOWN · sponsor: **Lady Davis Institute** · enrollment: 98 (estimated)

## Conditions studied

- Acneiform Eruptions
- Cancer, Treatment-Related

## Interventions

- **DRUG:** Doxycycline 100mg po once daily x 6 months
- **DRUG:** Isotretinoin 40 mg po once daily x 6 months

## Key facts

- **NCT ID:** NCT04864717
- **Lead sponsor:** Lady Davis Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04864717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04864717, "Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04864717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*